Lifestyle and Complementary Approaches to Polycystic Ovary Syndrome During Perimenopause and Menopause A Scoping Review
Abstract
Polycystic Ovary Syndrome (PCOS) persists across the lifespan, yet management during perimenopause and menopause remains underexplored. This scoping review examined non-pharmacological and non-surgical interventions for adult women with PCOS, with particular attention to lifestyle modifications, complementary approaches, and the influence of chronic pain and mental health on quality of life. Guided by the Arksey and O'Malley five-step framework and Joanna Briggs Institute recommendations, studies published in English from 2000 to 2024 were included. Eligible studies examined adult women with PCOS during perimenopause, menopause, or both, and reported on lifestyle interventions, complementary therapies, chronic pain, or quality-of-life outcomes. Twenty-nine studies met inclusion criteria. Diet and physical activity were the most commonly investigated interventions. More than 15 supplement categories were identified; however, none specifically targeted chronic pain or mental health outcomes. Only two studies addressed chronic pain management, both through dietary supplements. Exercise was the only intervention associated with mental health outcomes. PCOS management during perimenopause and menopause requires a holistic, person-centered approach integrating lifestyle and complementary strategies to address physical, hormonal, chronic pain, and mental health challenges.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.